Alastair Riddell
Chair
Nemesis Bioscience
United Kingdom
Biography
Alastair Riddell M.B., has over 30 years experience in the pharmaceutical, life science and biotech industries including 18 years as main board director, 12 years as CEO and is currently Chairman of the South West Academic Health Science Network and a non-executive director of 4 healthcare companies. He has taken a number of products through the clinical trials process for companies including Lederle (now Pfizer) and Centocor (now J&J). He has led significant fund raising efforts including an IPO on UK’s main list and trade sales to Takeda in Japan and Stem Cells Inc. in the USA. He has also had several roles in UK government initiatives related to promoting cooperation between pharmaceutical companies and the NHS and assessing projects for funding with Innovate UK.
Research Interest
Alastair has research interest in pharma, lifescience, biotech industry and business management.
